The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Bulk Drug Intermediates Market Research Report 2024

Global Bulk Drug Intermediates Market Research Report 2024

Publishing Date : May, 2024

License Type :
 

Report Code : 1996658

No of Pages : 98

Ask Your Query
Synopsis
The global Bulk Drug Intermediates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bulk Drug Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bulk Drug Intermediates.
Report Scope
The Bulk Drug Intermediates market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bulk Drug Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bulk Drug Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
Segment by Type
GMP
Non-GMP
Segment by Application
Antibiotics
Antipyretic Analgesics
Vitamins
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bulk Drug Intermediates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bulk Drug Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Bulk Drug Intermediates Market Overview
1.1 Product Overview and Scope of Bulk Drug Intermediates
1.2 Bulk Drug Intermediates Segment by Type
1.2.1 Global Bulk Drug Intermediates Market Value Comparison by Type (2024-2030)
1.2.2 GMP
1.2.3 Non-GMP
1.3 Bulk Drug Intermediates Segment by Application
1.3.1 Global Bulk Drug Intermediates Market Value by Application: (2024-2030)
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Global Bulk Drug Intermediates Market Size Estimates and Forecasts
1.4.1 Global Bulk Drug Intermediates Revenue 2019-2030
1.4.2 Global Bulk Drug Intermediates Sales 2019-2030
1.4.3 Global Bulk Drug Intermediates Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bulk Drug Intermediates Market Competition by Manufacturers
2.1 Global Bulk Drug Intermediates Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bulk Drug Intermediates Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bulk Drug Intermediates Average Price by Manufacturers (2019-2024)
2.4 Global Bulk Drug Intermediates Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bulk Drug Intermediates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bulk Drug Intermediates, Product Type & Application
2.7 Bulk Drug Intermediates Market Competitive Situation and Trends
2.7.1 Bulk Drug Intermediates Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bulk Drug Intermediates Players Market Share by Revenue
2.7.3 Global Bulk Drug Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bulk Drug Intermediates Retrospective Market Scenario by Region
3.1 Global Bulk Drug Intermediates Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bulk Drug Intermediates Global Bulk Drug Intermediates Sales by Region: 2019-2030
3.2.1 Global Bulk Drug Intermediates Sales by Region: 2019-2024
3.2.2 Global Bulk Drug Intermediates Sales by Region: 2025-2030
3.3 Global Bulk Drug Intermediates Global Bulk Drug Intermediates Revenue by Region: 2019-2030
3.3.1 Global Bulk Drug Intermediates Revenue by Region: 2019-2024
3.3.2 Global Bulk Drug Intermediates Revenue by Region: 2025-2030
3.4 North America Bulk Drug Intermediates Market Facts & Figures by Country
3.4.1 North America Bulk Drug Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bulk Drug Intermediates Sales by Country (2019-2030)
3.4.3 North America Bulk Drug Intermediates Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bulk Drug Intermediates Market Facts & Figures by Country
3.5.1 Europe Bulk Drug Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bulk Drug Intermediates Sales by Country (2019-2030)
3.5.3 Europe Bulk Drug Intermediates Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bulk Drug Intermediates Market Facts & Figures by Country
3.6.1 Asia Pacific Bulk Drug Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bulk Drug Intermediates Sales by Country (2019-2030)
3.6.3 Asia Pacific Bulk Drug Intermediates Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bulk Drug Intermediates Market Facts & Figures by Country
3.7.1 Latin America Bulk Drug Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bulk Drug Intermediates Sales by Country (2019-2030)
3.7.3 Latin America Bulk Drug Intermediates Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bulk Drug Intermediates Market Facts & Figures by Country
3.8.1 Middle East and Africa Bulk Drug Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bulk Drug Intermediates Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bulk Drug Intermediates Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bulk Drug Intermediates Sales by Type (2019-2030)
4.1.1 Global Bulk Drug Intermediates Sales by Type (2019-2024)
4.1.2 Global Bulk Drug Intermediates Sales by Type (2025-2030)
4.1.3 Global Bulk Drug Intermediates Sales Market Share by Type (2019-2030)
4.2 Global Bulk Drug Intermediates Revenue by Type (2019-2030)
4.2.1 Global Bulk Drug Intermediates Revenue by Type (2019-2024)
4.2.2 Global Bulk Drug Intermediates Revenue by Type (2025-2030)
4.2.3 Global Bulk Drug Intermediates Revenue Market Share by Type (2019-2030)
4.3 Global Bulk Drug Intermediates Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bulk Drug Intermediates Sales by Application (2019-2030)
5.1.1 Global Bulk Drug Intermediates Sales by Application (2019-2024)
5.1.2 Global Bulk Drug Intermediates Sales by Application (2025-2030)
5.1.3 Global Bulk Drug Intermediates Sales Market Share by Application (2019-2030)
5.2 Global Bulk Drug Intermediates Revenue by Application (2019-2030)
5.2.1 Global Bulk Drug Intermediates Revenue by Application (2019-2024)
5.2.2 Global Bulk Drug Intermediates Revenue by Application (2025-2030)
5.2.3 Global Bulk Drug Intermediates Revenue Market Share by Application (2019-2030)
5.3 Global Bulk Drug Intermediates Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Lonza
6.1.1 Lonza Corporation Information
6.1.2 Lonza Description and Business Overview
6.1.3 Lonza Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Lonza Bulk Drug Intermediates Product Portfolio
6.1.5 Lonza Recent Developments/Updates
6.2 Catalent
6.2.1 Catalent Corporation Information
6.2.2 Catalent Description and Business Overview
6.2.3 Catalent Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Catalent Bulk Drug Intermediates Product Portfolio
6.2.5 Catalent Recent Developments/Updates
6.3 Patheon
6.3.1 Patheon Corporation Information
6.3.2 Patheon Description and Business Overview
6.3.3 Patheon Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Patheon Bulk Drug Intermediates Product Portfolio
6.3.5 Patheon Recent Developments/Updates
6.4 Jubilant
6.4.1 Jubilant Corporation Information
6.4.2 Jubilant Description and Business Overview
6.4.3 Jubilant Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jubilant Bulk Drug Intermediates Product Portfolio
6.4.5 Jubilant Recent Developments/Updates
6.5 Granules
6.5.1 Granules Corporation Information
6.5.2 Granules Description and Business Overview
6.5.3 Granules Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Granules Bulk Drug Intermediates Product Portfolio
6.5.5 Granules Recent Developments/Updates
6.6 Ganesh
6.6.1 Ganesh Corporation Information
6.6.2 Ganesh Description and Business Overview
6.6.3 Ganesh Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ganesh Bulk Drug Intermediates Product Portfolio
6.6.5 Ganesh Recent Developments/Updates
6.7 Chemcon
6.6.1 Chemcon Corporation Information
6.6.2 Chemcon Description and Business Overview
6.6.3 Chemcon Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chemcon Bulk Drug Intermediates Product Portfolio
6.7.5 Chemcon Recent Developments/Updates
6.8 BASF
6.8.1 BASF Corporation Information
6.8.2 BASF Description and Business Overview
6.8.3 BASF Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BASF Bulk Drug Intermediates Product Portfolio
6.8.5 BASF Recent Developments/Updates
6.9 Porton
6.9.1 Porton Corporation Information
6.9.2 Porton Description and Business Overview
6.9.3 Porton Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Porton Bulk Drug Intermediates Product Portfolio
6.9.5 Porton Recent Developments/Updates
6.10 Lianhetech
6.10.1 Lianhetech Corporation Information
6.10.2 Lianhetech Description and Business Overview
6.10.3 Lianhetech Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lianhetech Bulk Drug Intermediates Product Portfolio
6.10.5 Lianhetech Recent Developments/Updates
6.11 ABA Chem
6.11.1 ABA Chem Corporation Information
6.11.2 ABA Chem Bulk Drug Intermediates Description and Business Overview
6.11.3 ABA Chem Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.11.4 ABA Chem Bulk Drug Intermediates Product Portfolio
6.11.5 ABA Chem Recent Developments/Updates
6.12 Tianma
6.12.1 Tianma Corporation Information
6.12.2 Tianma Bulk Drug Intermediates Description and Business Overview
6.12.3 Tianma Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Tianma Bulk Drug Intermediates Product Portfolio
6.12.5 Tianma Recent Developments/Updates
6.13 Jiujiujiu
6.13.1 Jiujiujiu Corporation Information
6.13.2 Jiujiujiu Bulk Drug Intermediates Description and Business Overview
6.13.3 Jiujiujiu Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jiujiujiu Bulk Drug Intermediates Product Portfolio
6.13.5 Jiujiujiu Recent Developments/Updates
6.14 Alpha
6.14.1 Alpha Corporation Information
6.14.2 Alpha Bulk Drug Intermediates Description and Business Overview
6.14.3 Alpha Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Alpha Bulk Drug Intermediates Product Portfolio
6.14.5 Alpha Recent Developments/Updates
6.15 Jiuzhou
6.15.1 Jiuzhou Corporation Information
6.15.2 Jiuzhou Bulk Drug Intermediates Description and Business Overview
6.15.3 Jiuzhou Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Jiuzhou Bulk Drug Intermediates Product Portfolio
6.15.5 Jiuzhou Recent Developments/Updates
6.16 Yongtai
6.16.1 Yongtai Corporation Information
6.16.2 Yongtai Bulk Drug Intermediates Description and Business Overview
6.16.3 Yongtai Bulk Drug Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Yongtai Bulk Drug Intermediates Product Portfolio
6.16.5 Yongtai Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bulk Drug Intermediates Industry Chain Analysis
7.2 Bulk Drug Intermediates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bulk Drug Intermediates Production Mode & Process
7.4 Bulk Drug Intermediates Sales and Marketing
7.4.1 Bulk Drug Intermediates Sales Channels
7.4.2 Bulk Drug Intermediates Distributors
7.5 Bulk Drug Intermediates Customers
8 Bulk Drug Intermediates Market Dynamics
8.1 Bulk Drug Intermediates Industry Trends
8.2 Bulk Drug Intermediates Market Drivers
8.3 Bulk Drug Intermediates Market Challenges
8.4 Bulk Drug Intermediates Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Bulk Drug Intermediates Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bulk Drug Intermediates Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Bulk Drug Intermediates Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bulk Drug Intermediates Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Bulk Drug Intermediates Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bulk Drug Intermediates Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bulk Drug Intermediates Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bulk Drug Intermediates Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bulk Drug Intermediates, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bulk Drug Intermediates, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bulk Drug Intermediates, Product Type & Application
Table 12. Global Key Manufacturers of Bulk Drug Intermediates, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bulk Drug Intermediates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bulk Drug Intermediates as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bulk Drug Intermediates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bulk Drug Intermediates Sales by Region (2019-2024) & (K Units)
Table 18. Global Bulk Drug Intermediates Sales Market Share by Region (2019-2024)
Table 19. Global Bulk Drug Intermediates Sales by Region (2025-2030) & (K Units)
Table 20. Global Bulk Drug Intermediates Sales Market Share by Region (2025-2030)
Table 21. Global Bulk Drug Intermediates Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bulk Drug Intermediates Revenue Market Share by Region (2019-2024)
Table 23. Global Bulk Drug Intermediates Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bulk Drug Intermediates Revenue Market Share by Region (2025-2030)
Table 25. North America Bulk Drug Intermediates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bulk Drug Intermediates Sales by Country (2019-2024) & (K Units)
Table 27. North America Bulk Drug Intermediates Sales by Country (2025-2030) & (K Units)
Table 28. North America Bulk Drug Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bulk Drug Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bulk Drug Intermediates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bulk Drug Intermediates Sales by Country (2019-2024) & (K Units)
Table 32. Europe Bulk Drug Intermediates Sales by Country (2025-2030) & (K Units)
Table 33. Europe Bulk Drug Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bulk Drug Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bulk Drug Intermediates Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bulk Drug Intermediates Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Bulk Drug Intermediates Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Bulk Drug Intermediates Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bulk Drug Intermediates Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bulk Drug Intermediates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bulk Drug Intermediates Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Bulk Drug Intermediates Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Bulk Drug Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bulk Drug Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Bulk Drug Intermediates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Bulk Drug Intermediates Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Bulk Drug Intermediates Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Bulk Drug Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Bulk Drug Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bulk Drug Intermediates Sales (K Units) by Type (2019-2024)
Table 51. Global Bulk Drug Intermediates Sales (K Units) by Type (2025-2030)
Table 52. Global Bulk Drug Intermediates Sales Market Share by Type (2019-2024)
Table 53. Global Bulk Drug Intermediates Sales Market Share by Type (2025-2030)
Table 54. Global Bulk Drug Intermediates Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bulk Drug Intermediates Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bulk Drug Intermediates Revenue Market Share by Type (2019-2024)
Table 57. Global Bulk Drug Intermediates Revenue Market Share by Type (2025-2030)
Table 58. Global Bulk Drug Intermediates Price (US$/Unit) by Type (2019-2024)
Table 59. Global Bulk Drug Intermediates Price (US$/Unit) by Type (2025-2030)
Table 60. Global Bulk Drug Intermediates Sales (K Units) by Application (2019-2024)
Table 61. Global Bulk Drug Intermediates Sales (K Units) by Application (2025-2030)
Table 62. Global Bulk Drug Intermediates Sales Market Share by Application (2019-2024)
Table 63. Global Bulk Drug Intermediates Sales Market Share by Application (2025-2030)
Table 64. Global Bulk Drug Intermediates Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bulk Drug Intermediates Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bulk Drug Intermediates Revenue Market Share by Application (2019-2024)
Table 67. Global Bulk Drug Intermediates Revenue Market Share by Application (2025-2030)
Table 68. Global Bulk Drug Intermediates Price (US$/Unit) by Application (2019-2024)
Table 69. Global Bulk Drug Intermediates Price (US$/Unit) by Application (2025-2030)
Table 70. Lonza Corporation Information
Table 71. Lonza Description and Business Overview
Table 72. Lonza Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Lonza Bulk Drug Intermediates Product
Table 74. Lonza Recent Developments/Updates
Table 75. Catalent Corporation Information
Table 76. Catalent Description and Business Overview
Table 77. Catalent Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Catalent Bulk Drug Intermediates Product
Table 79. Catalent Recent Developments/Updates
Table 80. Patheon Corporation Information
Table 81. Patheon Description and Business Overview
Table 82. Patheon Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Patheon Bulk Drug Intermediates Product
Table 84. Patheon Recent Developments/Updates
Table 85. Jubilant Corporation Information
Table 86. Jubilant Description and Business Overview
Table 87. Jubilant Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Jubilant Bulk Drug Intermediates Product
Table 89. Jubilant Recent Developments/Updates
Table 90. Granules Corporation Information
Table 91. Granules Description and Business Overview
Table 92. Granules Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Granules Bulk Drug Intermediates Product
Table 94. Granules Recent Developments/Updates
Table 95. Ganesh Corporation Information
Table 96. Ganesh Description and Business Overview
Table 97. Ganesh Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Ganesh Bulk Drug Intermediates Product
Table 99. Ganesh Recent Developments/Updates
Table 100. Chemcon Corporation Information
Table 101. Chemcon Description and Business Overview
Table 102. Chemcon Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Chemcon Bulk Drug Intermediates Product
Table 104. Chemcon Recent Developments/Updates
Table 105. BASF Corporation Information
Table 106. BASF Description and Business Overview
Table 107. BASF Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. BASF Bulk Drug Intermediates Product
Table 109. BASF Recent Developments/Updates
Table 110. Porton Corporation Information
Table 111. Porton Description and Business Overview
Table 112. Porton Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Porton Bulk Drug Intermediates Product
Table 114. Porton Recent Developments/Updates
Table 115. Lianhetech Corporation Information
Table 116. Lianhetech Description and Business Overview
Table 117. Lianhetech Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Lianhetech Bulk Drug Intermediates Product
Table 119. Lianhetech Recent Developments/Updates
Table 120. ABA Chem Corporation Information
Table 121. ABA Chem Description and Business Overview
Table 122. ABA Chem Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. ABA Chem Bulk Drug Intermediates Product
Table 124. ABA Chem Recent Developments/Updates
Table 125. Tianma Corporation Information
Table 126. Tianma Description and Business Overview
Table 127. Tianma Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Tianma Bulk Drug Intermediates Product
Table 129. Tianma Recent Developments/Updates
Table 130. Jiujiujiu Corporation Information
Table 131. Jiujiujiu Description and Business Overview
Table 132. Jiujiujiu Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Jiujiujiu Bulk Drug Intermediates Product
Table 134. Jiujiujiu Recent Developments/Updates
Table 135. Alpha Corporation Information
Table 136. Alpha Description and Business Overview
Table 137. Alpha Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Alpha Bulk Drug Intermediates Product
Table 139. Alpha Recent Developments/Updates
Table 140. Jiuzhou Corporation Information
Table 141. Jiuzhou Description and Business Overview
Table 142. Jiuzhou Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Jiuzhou Bulk Drug Intermediates Product
Table 144. Jiuzhou Recent Developments/Updates
Table 145. Yongtai Corporation Information
Table 146. Yongtai Description and Business Overview
Table 147. Yongtai Bulk Drug Intermediates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Yongtai Bulk Drug Intermediates Product
Table 149. Yongtai Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Bulk Drug Intermediates Distributors List
Table 153. Bulk Drug Intermediates Customers List
Table 154. Bulk Drug Intermediates Market Trends
Table 155. Bulk Drug Intermediates Market Drivers
Table 156. Bulk Drug Intermediates Market Challenges
Table 157. Bulk Drug Intermediates Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bulk Drug Intermediates
Figure 2. Global Bulk Drug Intermediates Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bulk Drug Intermediates Market Share by Type in 2023 & 2030
Figure 4. GMP Product Picture
Figure 5. Non-GMP Product Picture
Figure 6. Global Bulk Drug Intermediates Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Bulk Drug Intermediates Market Share by Application in 2023 & 2030
Figure 8. Antibiotics
Figure 9. Antipyretic Analgesics
Figure 10. Vitamins
Figure 11. Others
Figure 12. Global Bulk Drug Intermediates Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Bulk Drug Intermediates Market Size (2019-2030) & (US$ Million)
Figure 14. Global Bulk Drug Intermediates Sales (2019-2030) & (K Units)
Figure 15. Global Bulk Drug Intermediates Average Price (US$/Unit) & (2019-2030)
Figure 16. Bulk Drug Intermediates Report Years Considered
Figure 17. Bulk Drug Intermediates Sales Share by Manufacturers in 2023
Figure 18. Global Bulk Drug Intermediates Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Bulk Drug Intermediates Players: Market Share by Revenue in 2023
Figure 20. Bulk Drug Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Bulk Drug Intermediates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Bulk Drug Intermediates Sales Market Share by Country (2019-2030)
Figure 23. North America Bulk Drug Intermediates Revenue Market Share by Country (2019-2030)
Figure 24. United States Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Bulk Drug Intermediates Sales Market Share by Country (2019-2030)
Figure 27. Europe Bulk Drug Intermediates Revenue Market Share by Country (2019-2030)
Figure 28. Germany Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Bulk Drug Intermediates Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Bulk Drug Intermediates Revenue Market Share by Region (2019-2030)
Figure 35. China Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Bulk Drug Intermediates Sales Market Share by Country (2019-2030)
Figure 45. Latin America Bulk Drug Intermediates Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Bulk Drug Intermediates Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Bulk Drug Intermediates Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Bulk Drug Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Bulk Drug Intermediates by Type (2019-2030)
Figure 55. Global Revenue Market Share of Bulk Drug Intermediates by Type (2019-2030)
Figure 56. Global Bulk Drug Intermediates Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Bulk Drug Intermediates by Application (2019-2030)
Figure 58. Global Revenue Market Share of Bulk Drug Intermediates by Application (2019-2030)
Figure 59. Global Bulk Drug Intermediates Price (US$/Unit) by Application (2019-2030)
Figure 60. Bulk Drug Intermediates Value Chain
Figure 61. Bulk Drug Intermediates Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock